This is a novel randomized trial of the impact of treating selected medical conditions at home in patients presenting to an emergency department. Of 91 patients, 43 received care at home and 48 received usual care in the hospital. Most patients had heart failure, an acute infection, or COPD and were required to live independently within five miles of the hospital and be able to walk with assistance of one person to reach a bedside commode. The adjusted mean cost of the acute care episode was 38% (95% CI, 24% to 49%) lower for home patients than control patients. The primary outcome was cost of care. Home patients had fewer laboratory orders (3 vs. 15), imaging studies (14% vs. 44%), and consultations (2% vs. 31%). Home patients were less sedentary (median, 12% vs. 23%) and had a marked reduction in readmissions within 30 days (7% vs. 23%). They conclude that the hospital at home model in selected patients led to significant cost savings. This may represent a new model of care in the United States, whereby patients with non-critical illness may be treated at home.